{"notes_translated":{"fr":"Le FEMC fournit aux universitaires, aux chercheurs, aux décideurs et aux dirigeants de l’information objective et comparable information sur l’ampleur des coûts de la maladie et des blessures au Canada. Le FEMC fournit une vue d’ensemble de la répartition des coûts directs et indirects attribuables à la maladie et aux blessures au Canada","en":"EBIC provides academics, researchers, decision-makers, and policy-makers with objective and comparable information on the magnitude of the cost of illness and injury in Canada. EBIC provides a comprehensive overview of the distribution of direct and indirect costs of illness and injury in Canada."},"imso_approval":"true","maintainer":null,"creator":"","association_type":[],"org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"contributor":{"fr":"","en":""},"frequency":"as_needed","keywords":{"fr":["FEMC 2010","Le fardeau économique de la maladie au Canada","coûts des médicaments"],"en":["EBIC 2010","Economic Burden of Illness in Canada","Drug Cost"]},"data_series_issue_identification":{"fr":"","en":""},"ready_to_publish":"true","id":"72a75f1f-da4d-48fc-b0eb-177261df1fc4","metadata_created":"2019-05-09T19:40:59.994982","subject":["health_and_safety"],"spatial_representation_type":[],"metadata_modified":"2019-05-09T19:40:59.994991","author":null,"author_email":null,"geographic_region":[],"position_name":{},"portal_release_date":"2019-05-09","digital_object_identifier":"","state":"active","version":null,"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Coût des médicaments Âgé de 0 à 75 plus","en":"Drug Cost Age 0 to 75 plus"},"type":"dataset","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"72a75f1f-da4d-48fc-b0eb-177261df1fc4","datastore_active":false,"id":"079dcd6a-57fa-4f7d-ae88-aca2ea80cd34","character_set":"","state":"active","name_translated":{"fr":"Coût des médicaments Âgé de 0 à 75 plus","en":"Drug Cost Age 0 to 75 plus"},"hash":"","description":"","format":"CSV","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Drug Cost Age 0 to 75 plus","language":["en"],"created":"2019-05-09T19:41:00.833816","url":"http://health.canada.ca/apps/open-data/ebic/EBIC2010DrugCostEnglish.csv","last_modified":null,"resource_type":"dataset","position":0,"revision_id":"aa0cbe3b-5d6b-4f48-9dfb-16f2751eb662","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"72a75f1f-da4d-48fc-b0eb-177261df1fc4","datastore_active":false,"id":"5284b638-596d-44fd-8028-7f6b9c93233d","character_set":"","state":"active","name_translated":{"fr":"Coût des médicaments Âgé de 0 à 75 plus","en":"Drug Cost Age 0 to 75 plus"},"hash":"","description":"","format":"CSV","date_published":"2014-03-30","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Drug Cost Age 0 to 75 plus","language":["fr"],"created":"2019-05-09T19:41:00.833825","url":"http://health.canada.ca/apps/open-data/ebic/EBIC2010DrugCostFrench.csv","last_modified":null,"resource_type":"dataset","position":1,"revision_id":"aa0cbe3b-5d6b-4f48-9dfb-16f2751eb662","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"72a75f1f-da4d-48fc-b0eb-177261df1fc4","datastore_active":false,"id":"6e3810a7-4fe8-4f48-b005-01687124f942","character_set":"","state":"active","name_translated":{"fr":"Le fardeau économique de la maladie au Canada, 2010","en":"Economic Burden of Illness in Canada, 2010"},"hash":"","description":"","format":"PDF","date_published":"2014-03-30","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Economic Burden of Illness in Canada, 2010","language":["en"],"created":"2019-05-09T19:41:00.833829","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/science-research/economic-burden-illness-canada-2010/economic-burden-illness-canada-2010.pdf","last_modified":null,"resource_type":"website","position":2,"revision_id":"aa0cbe3b-5d6b-4f48-9dfb-16f2751eb662","data_quality":[]},{"cache_last_updated":null,"unique_identifier":"","package_id":"72a75f1f-da4d-48fc-b0eb-177261df1fc4","datastore_active":false,"id":"3cdca947-c910-4cb0-a6d6-4392c3c9d6e6","character_set":"","state":"active","name_translated":{"fr":"Le fardeau économique de la maladie au Canada, 2010","en":"Economic Burden of Illness in Canada, 2010"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Economic Burden of Illness in Canada, 2010","language":["fr"],"created":"2019-05-09T19:41:00.833831","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/science-research/economic-burden-illness-canada-2010/fardeau-economique-maladie-canada-2010.pdf","last_modified":null,"resource_type":"website","position":3,"revision_id":"aa0cbe3b-5d6b-4f48-9dfb-16f2751eb662","data_quality":[]}],"place_of_publication":[],"metadata_contact":{},"num_resources":4,"topic_category":[],"tags":[],"spatial":"","collection":"primary","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2014-03-30 00:00:00","display_flags":[],"groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"72a75f1f-da4d-48fc-b0eb-177261df1fc4","isopen":false,"url":null,"notes":"EBIC provides academics, researchers, decision-makers, and policy-makers with objective and comparable information on the magnitude of the cost of illness and injury in Canada. EBIC provides a comprehensive overview of the distribution of direct and indirect costs of illness and injury in Canada.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","audience":[],"license_url":"http://open.canada.ca/en/open-government-licence-canada","program_page_url":{"fr":"","en":""},"title":"Drug Cost Age 0 to 75 plus","revision_id":"aa0cbe3b-5d6b-4f48-9dfb-16f2751eb662"}